GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 17 filers reported holding GAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,568 | -26.8% | 58,100 | 0.0% | 0.01% | -29.4% |
| Q2 2023 | $260,288 | -7.1% | 58,100 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $280,042 | +54.0% | 58,100 | 0.0% | 0.02% | +88.9% |
| Q4 2022 | $181,853 | -3.8% | 58,100 | 0.0% | 0.01% | +28.6% |
| Q3 2022 | $189,000 | -9.6% | 58,100 | 0.0% | 0.01% | +16.7% |
| Q2 2022 | $209,000 | -12.2% | 58,100 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $238,000 | -24.4% | 58,100 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $315,000 | -27.3% | 58,100 | 0.0% | 0.01% | -27.3% |
| Q3 2021 | $433,000 | -25.5% | 58,100 | 0.0% | 0.01% | -35.3% |
| Q2 2021 | $581,000 | -33.0% | 58,100 | 0.0% | 0.02% | -22.7% |
| Q1 2021 | $867,000 | – | 58,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 30,293 | $303,000 | 0.42% |
| Greenlight Capital | 546,560 | $5,466,000 | 0.34% |
| CM Management, LLC | 10,000 | $100,000 | 0.07% |
| Granite Point Capital Management, L.P. | 155,709 | $1,559,000 | 0.06% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $581,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $501,000 | 0.01% |
| Banque Cantonale Vaudoise | 3,000 | $30,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 23,878 | $239,000 | 0.00% |
| MORGAN STANLEY | 800 | $8,000 | 0.00% |
| BlackRock Inc. | 11,659 | $116,000 | 0.00% |